MPG.eBooks - Search Results

81

CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

82

Anti-vascular endothelial growth factor drugs for the treatment of retinal conditions : a review of the safety

by Deonandan, Raywat, Jones, Sarah
Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors...”

Read Now

83

Drug class review: Direct renin inhibitors, angiotensin converting enzyme inhibitors, and angiotensin II receptor blockers : final report

by Norris, Susan L., Weinstein, Jessica, Peterson, Kim, Thakurta, Sujata
Published 2010

Oregon Health & Science University

Subjects: “...Angiotensin-Converting Enzyme Inhibitors / therapeutic use...”

Read Now

84

Aromatase inhibitors in the treatment of early ER-positive breast cancer in post-menopausal women

Published 2014

Swedish Council on Health Technology Assessment (SBU)

Subjects: “...Aromatase Inhibitors / therapeutic use...”

Read Now

85

Drug class review: Direct renin inhibitors, angiotensin converting enzyme inhibitors, and angiotensin II receptor blockers : final report

by Norris, Susan L., Weinstein, Jessica, Peterson, Kim, Thakurta, Sujata
Published 2010

Oregon Health & Science University

Subjects: “...Angiotensin-Converting Enzyme Inhibitors / therapeutic use...”

Read Now

86

Anti-vascular endothelial growth factor drugs for the treatment of retinal conditions : a review of the safety

by Deonandan, Raywat, Jones, Sarah
Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors...”

Read Now

87

State of the Art in Idiopathic Pulmonary Fibrosis

by Wygrecka, Malgorzata
Published 2023

MDPI - Multidisciplinary Digital Publishing Institute

Subjects: “...Class I-HDAC-inhibitor...”

Read Now

88

Nitisinone (MDK-nitisinone) : (MendeliKABS inc.) : indication : for the treatment of patients with hereditary tyrosinemia type 1 in combination with dietary restriction of tyrosine...

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Enzyme Inhibitors / therapeutic use...”

Read Now

89

Anti-vascular endothelial growth factor drugs for retinal conditions : a therapeutic review

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors...”

Read Now

90

NTP developmental and reproductive toxicity technical report on the prenatal development studies of vinpocetine (CASRN 42971-09-5) in Sprague Dawley (Hsd: Sprague Dawley SD) rats a...

Published 2020

National Toxicology Program, Public Health Service, U.S. Department of Health and Human Services

Subjects: “...Phosphodiesterase Inhibitors / toxicity...”

Read Now

91

Anti-vascular endothelial growth factor drugs for retinal conditions : a therapeutic review

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors...”

Read Now

92

Nitisinone (MDK-nitisinone) : (MendeliKABS inc.) : indication : for the treatment of patients with hereditary tyrosinemia type 1 in combination with dietary restriction of tyrosine...

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Enzyme Inhibitors / therapeutic use...”

Read Now

93

Phosphodiesterase type 5 inhibitors for penile rehabilitation post radical prostatectomy : a review of clinical effectiveness and guidelines

by Kaulback, Kellee, Argáez, Charlene
Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Phosphodiesterase 5 Inhibitors / therapeutic use...”

Read Now

94

Sodium-glucose cotransporter 2 inhibitors for the treatment of diabetic nephropathy : a review of clinical effectiveness

by Banerjee, Srabani, Grobelna, Aleksandra
Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

95

Phosphodiesterase type 5 inhibitors for penile rehabilitation post radical prostatectomy : a review of clinical effectiveness and guidelines

by Kaulback, Kellee, Argáez, Charlene
Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Phosphodiesterase 5 Inhibitors / therapeutic use...”

Read Now

96

Bleeding peptic ulcer : a systematic review : summary and conclusions

Published 2011

Swedish Council on Health Technology Assessment

Subjects: “...Proton Pump Inhibitors / therapeutic use...”

Read Now

97

Pre-endoscopic intravenous proton pump inhibitors for emergency department patients with upper gastrointestinal bleeds : a review of clinical effectiveness, cost-effectiveness, and...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Proton Pump Inhibitors / administration & dosage...”

Read Now

98

The role of arginase in endothelial dysfunction

by Rudolf Lucas
Published 2015

Frontiers Media SA

Subjects: “...arginase inhibitors...”

Read Now

99

Nephrotic Syndrome in Pediatric Patients

by Frederick Jeffrey Kaskel
Published 2017

Frontiers Media SA

Subjects: “...calcineurin inhibitors...”

Read Now

100

Pre-endoscopic intravenous proton pump inhibitors for emergency department patients with upper gastrointestinal bleeds : a review of clinical effectiveness, cost-effectiveness, and...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Proton Pump Inhibitors / administration & dosage...”

Narrow Search